首页 > 最新文献

Interventional Medicine and Applied Science最新文献

英文 中文
Plasma interleukin-6 levels correlate with survival in patients with bacterial sepsis and septic shock. 血浆白细胞介素-6水平与细菌性败血症和感染性休克患者的生存相关。
Q2 Medicine Pub Date : 2021-08-02 eCollection Date: 2021-08-01 DOI: 10.1556/1646.2020.00006
Monica Chavez Vivas, Hector Fabio Villamarin Guerrero, Antonio Jose Tascon, Augusto Valderrama-Aguirre

In this study, IL-6 levels were assessed as inflammatory biomarker of bacterial sepsis in patients hospitalized at the ICU of the hospital of Colombia.

Materials and methods: Prospective study on 62 patients diagnosed with sepsis and septic shock. An ELISA assay was used to test serum levels of IL-6 at admission and 48 h after admission. Variables were analyzed by χ2 test (alfa <0.05). Multivariable Cox regression was used to determine the survival with the statistical program SPSS v23.00.

Results: Patient's median age was 53 years old and 59.7% were male. Lung was the most common primary site of infection (43.5%), and hypertension comorbidity with higher prevalence (40%). Infection by Gram negative bacteria were significantly more frequent among patients than Gram positive (P = 0.037). Overall, survival analysis showed that 10 (16.1%) patients died with a survival median of 7.00 +4.874 (2-3) days. In patients with sepsis we detected a significant decline in the average of IL-6 serum levels after 48 h of admission [7.50 (SD: 7.00-68.00) pg/mL vs. 68.00 [SD: 7.00-300.00] pg/mL (P = 0.000). Only 25% of patients with septic shock who presented high levels of IL-6 at the time of admission and at 48 h had a survival up to 15 days (P = 0.005).

Conclusion: We found significant differences between the plasma levels of IL-6 during the first 48 h after admission to the ICU among patients with sepsis and septic shock. Patients with sepsis had a significant decline in IL-6 levels, whereas in patients who developed septic shock, levels of this cytokine remained high and have a lower survival compared to those who maintained low levels of IL-6.

在本研究中,IL-6水平被评估为哥伦比亚医院ICU住院患者细菌性脓毒症的炎症生物标志物。材料与方法:对62例诊断为脓毒症及感染性休克的患者进行前瞻性研究。采用ELISA法检测入院时和入院后48 h血清IL-6水平。结果:患者中位年龄53岁,男性占59.7%。肺部是最常见的原发感染部位(43.5%),高血压合并症患病率较高(40%)。革兰氏阴性菌感染发生率明显高于革兰氏阳性菌(P = 0.037)。总体而言,生存分析显示10例(16.1%)患者死亡,生存中位数为7.00 +4.874(2-3)天。在脓毒症患者中,我们发现入院48小时后血清IL-6平均水平显著下降[7.50 (SD: 7.00-68.00) pg/mL vs. 68.00 [SD: 7.00-300.00] pg/mL (P = 0.000)。只有25%的脓毒性休克患者在入院时和48小时出现高水平的IL-6,生存时间长达15天(P = 0.005)。结论:脓毒症与感染性休克患者入院后48 h血浆IL-6水平差异有统计学意义。脓毒症患者的IL-6水平显著下降,而脓毒症休克患者的IL-6水平仍然很高,与IL-6水平较低的患者相比,生存率较低。
{"title":"Plasma interleukin-6 levels correlate with survival in patients with bacterial sepsis and septic shock.","authors":"Monica Chavez Vivas,&nbsp;Hector Fabio Villamarin Guerrero,&nbsp;Antonio Jose Tascon,&nbsp;Augusto Valderrama-Aguirre","doi":"10.1556/1646.2020.00006","DOIUrl":"https://doi.org/10.1556/1646.2020.00006","url":null,"abstract":"<p><p>In this study, IL-6 levels were assessed as inflammatory biomarker of bacterial sepsis in patients hospitalized at the ICU of the hospital of Colombia.</p><p><strong>Materials and methods: </strong>Prospective study on 62 patients diagnosed with sepsis and septic shock. An ELISA assay was used to test serum levels of IL-6 at admission and 48 h after admission. Variables were analyzed by <i>χ</i>2 test (alfa <0.05). Multivariable Cox regression was used to determine the survival with the statistical program SPSS v23.00.</p><p><strong>Results: </strong>Patient's median age was 53 years old and 59.7% were male. Lung was the most common primary site of infection (43.5%), and hypertension comorbidity with higher prevalence (40%). Infection by Gram negative bacteria were significantly more frequent among patients than Gram positive (<i>P</i> = 0.037). Overall, survival analysis showed that 10 (16.1%) patients died with a survival median of 7.00 +4.874 (2-3) days. In patients with sepsis we detected a significant decline in the average of IL-6 serum levels after 48 h of admission [7.50 (SD: 7.00-68.00) pg/mL vs. 68.00 [SD: 7.00-300.00] pg/mL (<i>P</i> = 0.000). Only 25% of patients with septic shock who presented high levels of IL-6 at the time of admission and at 48 h had a survival up to 15 days (<i>P</i> = 0.005).</p><p><strong>Conclusion: </strong>We found significant differences between the plasma levels of IL-6 during the first 48 h after admission to the ICU among patients with sepsis and septic shock. Patients with sepsis had a significant decline in IL-6 levels, whereas in patients who developed septic shock, levels of this cytokine remained high and have a lower survival compared to those who maintained low levels of IL-6.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/05/imas-11-224.PMC9467384.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
ln vitro inhibition of beta-hematin formation and in vivo effects of Diospyros mespiliformis and Mondia whitei methanol extracts on chloroquine-susceptible Plasmodium berghei-induced malaria in mice. 刺螺和白念珠菌甲醇提取物对伯氏疟原虫致氯喹敏感小鼠疟疾的体外抑制及体内作用
Q2 Medicine Pub Date : 2021-07-20 eCollection Date: 2021-08-01 DOI: 10.1556/1646.2020.00001
John Oludele Olanlokun, Janet Adenike Adetutu, Olabode Olufunso Olorunsogo

Background and aim: This study was carried out to investigate antiplasmodial activities of Diospyros mespiliformis (DM) and Mondia whitei (MW) in Plasmodium berghei-infected mice.

Materials and methods: Air-dried stem of DM and root of MW were soaked in methanol, decanted and concentrated to give extracts. Parts of these extracts were partitioned successively to give dichloromethane, ethylacetate and methanol fractions. Mice (18 ± 3 g) were infected with Plasmodium berghei-infected erythrocytes from a donor mouse and were treated with the extracts, while the drug control group received 10 mg/kg body weight of artesunate and the parasitized control received the vehicle (5% v/v DMSO). Percentage parasitemia and clearance were estimated from thin films of blood smear. Hematological parameters were determined using standard methods. Both extracts were also tested on in vitro inhibition of β-hematin formation.

Results discussion and conclusion: Results showed that DM had the least percentage parasitemia (0.67%) and highest percentage parasite clearance (84.7%) while the MW had 0.89% percentage parasitemia and 79.7% clearance at the highest dose used after the seventh day relative to untreated control. The cell free antiplasmodial activity of the fractions and extracts of both DM and MW revealed that DM significantly inhibited β-hematin formation than MW. The packed cell volume, white blood cell count, Lymphocyte, Eosinophil, Monocyte and Neutrophil significantly increased in the treated groups compared with the control. The results showed that the DM had higher antiplasmodial activity.

背景与目的:研究白念珠菌(MW)和中螺孢子虫(DM)在伯氏疟原虫感染小鼠体内的抗疟原虫活性。材料与方法:DM茎风干,MW根甲醇浸泡,滗析浓缩得到提取物。这些萃取物的部分被依次分割得到二氯甲烷、乙酸乙酯和甲醇馏分。小鼠(18±3 g)感染供体小鼠贝格黑疟原虫感染的红细胞,用其提取物处理,药物对照组给予10 mg/kg体重的青蒿琥酯,寄生对照组给予5% v/v DMSO的载药。通过血涂片估计寄生虫率和清除率。采用标准方法测定血液学参数。两种提取物对β-血红素形成的体外抑制作用也进行了测试。结果讨论与结论:结果在第7天使用最高剂量时,DM鼠的寄生虫率最低(0.67%),寄生虫清除率最高(84.7%),而MW鼠的寄生虫率为0.89%,清除率为79.7%。DM和MW组分和提取物的细胞游离抗疟原虫活性显示DM比MW显著抑制β-血红素的形成。与对照组相比,治疗组的堆积细胞体积、白细胞计数、淋巴细胞、嗜酸性粒细胞、单核细胞和中性粒细胞显著增加。结果表明,DM具有较高的抗疟原虫活性。
{"title":"<i>ln vitro</i> inhibition of beta-hematin formation and <i>in vivo</i> effects of <i>Diospyros mespiliformis</i> and <i>Mondia whitei</i> methanol extracts on chloroquine-susceptible <i>Plasmodium berghei</i>-induced malaria in mice.","authors":"John Oludele Olanlokun,&nbsp;Janet Adenike Adetutu,&nbsp;Olabode Olufunso Olorunsogo","doi":"10.1556/1646.2020.00001","DOIUrl":"https://doi.org/10.1556/1646.2020.00001","url":null,"abstract":"<p><strong>Background and aim: </strong>This study was carried out to investigate antiplasmodial activities of <i>Diospyros mespiliformis</i> (<i>DM</i>) and <i>Mondia whitei</i> (<i>MW</i>) in <i>Plasmodium berghei</i>-infected mice.</p><p><strong>Materials and methods: </strong>Air-dried stem of <i>DM</i> and root of <i>MW</i> were soaked in methanol, decanted and concentrated to give extracts. Parts of these extracts were partitioned successively to give dichloromethane, ethylacetate and methanol fractions. Mice (18 ± 3 g) were infected with <i>Plasmodium berghei</i>-infected erythrocytes from a donor mouse and were treated with the extracts, while the drug control group received 10 mg/kg body weight of artesunate and the parasitized control received the vehicle (5% v/v DMSO). Percentage parasitemia and clearance were estimated from thin films of blood smear. Hematological parameters were determined using standard methods. Both extracts were also tested on <i>in vitro</i> inhibition of β-hematin formation.</p><p><strong>Results discussion and conclusion: </strong>Results showed that <i>DM</i> had the least percentage parasitemia (0.67%) and highest percentage parasite clearance (84.7%) while the <i>MW</i> had 0.89% percentage parasitemia and 79.7% clearance at the highest dose used after the seventh day relative to untreated control. The cell free antiplasmodial activity of the fractions and extracts of both <i>DM</i> and <i>MW</i> revealed that <i>DM</i> significantly inhibited β-hematin formation than <i>MW</i>. The packed cell volume, white blood cell count, Lymphocyte, Eosinophil, Monocyte and Neutrophil significantly increased in the treated groups compared with the control. The results showed that the <i>DM</i> had higher antiplasmodial activity.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bc/dc/imas-11-197.PMC9467386.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40686213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Levels of glucagon-like peptide 1 in hyperemesis gravidarum. 妊娠剧吐中胰高血糖素样肽1的水平。
Q2 Medicine Pub Date : 2021-07-20 eCollection Date: 2021-08-01 DOI: 10.1556/1646.2020.00003
Ayla Aktulay, Y Engin-Ustun, O Kaymak, Ayse Seval Ozgu-Erdinc, Canan Demirtas, Mustafa Kara, Nuri Danisman, Salim Erkaya

Objective: Glucagon-like peptide 1 (GLP-1), a gut-derived peptide has been reported to have insulin-like effects. Our aim is to examine GLP1 levels in hyperemesis gravidarum (HEG).

Materials-methods: The study population consisted of 2 groups: Group 1 (control subjects) consisted of 22 women with uncomplicated singleton pregnancies in the first trimester. Group 2 consisted of 22 singleton pregnancies complicated by HEG. Glucose and GLP1 levels were determined. Enzyme-linked Immunosorbent Assay Kit for Glucagon like Peptide 1 (GLP1) was used (Uscn, Life Science Inc.).

Results: No significant differences in maternal age, gestational age and gravida were observed between hypermetric and control groups. Maternal serum GLP1 levels were significantly higher in HEG compared with control group (P = 0.004).

Conclusion: The results of our study revealed that the presence of increased GLP1 levels in women with HEG could contribute to the pathogenesis of the disease. Our results indicated that increased GLP1 levels may be associated with hyperemesis gravidarum. The limitation of our study was the restricted number of patients. Large prospective and randomized studies are required to evaluate the effect of GLP1 levels on hyperemesis gravidarum.

目的:胰高血糖素样肽1 (GLP-1)是一种肠道来源的肽,据报道具有胰岛素样作用。我们的目的是检测GLP1在妊娠剧吐(HEG)中的水平。材料-方法:研究人群分为两组:第一组(对照组)包括22例妊娠早期无并发症的单胎妊娠妇女。第二组为22例合并HEG的单胎妊娠。测定葡萄糖和GLP1水平。使用胰高血糖素样肽1 (GLP1)酶联免疫吸附测定试剂盒(Uscn, Life Science Inc.)。结果:高氧组与对照组在产妇年龄、胎龄和产程上均无显著差异。HEG组孕妇血清GLP1水平显著高于对照组(P = 0.004)。结论:我们的研究结果表明,女性HEG患者中GLP1水平升高可能与HEG的发病机制有关。我们的研究结果表明,GLP1水平升高可能与妊娠剧吐有关。本研究的局限性在于患者数量有限。评估GLP1水平对妊娠剧吐的影响需要大规模的前瞻性和随机研究。
{"title":"Levels of glucagon-like peptide 1 in hyperemesis gravidarum.","authors":"Ayla Aktulay,&nbsp;Y Engin-Ustun,&nbsp;O Kaymak,&nbsp;Ayse Seval Ozgu-Erdinc,&nbsp;Canan Demirtas,&nbsp;Mustafa Kara,&nbsp;Nuri Danisman,&nbsp;Salim Erkaya","doi":"10.1556/1646.2020.00003","DOIUrl":"https://doi.org/10.1556/1646.2020.00003","url":null,"abstract":"<p><strong>Objective: </strong>Glucagon-like peptide 1 (GLP-1), a gut-derived peptide has been reported to have insulin-like effects. Our aim is to examine GLP1 levels in hyperemesis gravidarum (HEG).</p><p><strong>Materials-methods: </strong>The study population consisted of 2 groups: Group 1 (control subjects) consisted of 22 women with uncomplicated singleton pregnancies in the first trimester. Group 2 consisted of 22 singleton pregnancies complicated by HEG. Glucose and GLP1 levels were determined. Enzyme-linked Immunosorbent Assay Kit for Glucagon like Peptide 1 (GLP1) was used (Uscn, Life Science Inc.).</p><p><strong>Results: </strong>No significant differences in maternal age, gestational age and gravida were observed between hypermetric and control groups. Maternal serum GLP1 levels were significantly higher in HEG compared with control group (<i>P</i> = 0.004).</p><p><strong>Conclusion: </strong>The results of our study revealed that the presence of increased GLP1 levels in women with HEG could contribute to the pathogenesis of the disease. Our results indicated that increased GLP1 levels may be associated with hyperemesis gravidarum. The limitation of our study was the restricted number of patients. Large prospective and randomized studies are required to evaluate the effect of GLP1 levels on hyperemesis gravidarum.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/9b/imas-11-213.PMC9467383.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40452651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulsation of catheter during coronary angiography: Is it a sign of severe aortic regurgitation? 冠状动脉造影时导管搏动:是主动脉严重反流的征兆吗?
Q2 Medicine Pub Date : 2021-07-17 eCollection Date: 2021-08-01 DOI: 10.1556/1646.2020.00005
Muzaffer Kahyaoglu, Cetin Gecmen, Ozkan Candan

A 48-year-old male patient was admitted to our outpatient clinic with complaints of shortness of breath. He also had a holo-diastolic murmur at the right sternal border and an apical impulse being displaced laterally and inferiorly. Transthoracic echocardiography showed a severe aortic regurgitation without aortic valve stenosis and a mildly dilated left ventricle accompanied by an ejection fraction of 55%. The aortic regurgitation jet was eccentric and there were significant holodiastolic flow reversals in the descending thoracic aorta. Surgical management was advised for this patient because of symptomatic severe aortic regurgitation. Then, the patient underwent preoperative coronary angiography through the right femoral artery route. The left coronary ostium could be engaged with a 6 Fr Judkins left diagnostic catheter; however, the catheter jumped through the ascending aorta. Afterwards, the catheter was engaged and again jumped through the ascending aorta. Engagement and jumping cycles observed between successive systole to diastole. In our opinion, this catheter movement is explained by wide pulse pressure, like the severe characteristic physical findings of severe aortic regurgitation. Further studies are needed to understand whether this catheter movement is angiographically evidence of severe aortic regurgitation.

一名48岁男性病人以呼吸短促主诉入住我们的门诊。右胸骨边界有全舒张期杂音,心尖冲激向外侧和下方移位。经胸超声心动图显示严重主动脉反流,无主动脉瓣狭窄,左心室轻度扩张,伴射血分数55%。主动脉反流射流偏心,胸降主动脉舒张期血流明显逆转。由于严重的主动脉反流症状,建议对该患者进行手术治疗。然后,患者通过右股动脉行术前冠状动脉造影。左冠状动脉口可用6 Fr Judkins左诊断导管;然而,导管跳穿了升主动脉。之后,导管被接合并再次跳穿升主动脉。在连续收缩期到舒张期之间观察到接合和跳跃周期。我们认为,这种导管移动是由宽脉压引起的,就像严重主动脉反流的严重特征性物理表现一样。需要进一步的研究来了解这种导管运动是否是严重主动脉反流的血管造影证据。
{"title":"Pulsation of catheter during coronary angiography: Is it a sign of severe aortic regurgitation?","authors":"Muzaffer Kahyaoglu,&nbsp;Cetin Gecmen,&nbsp;Ozkan Candan","doi":"10.1556/1646.2020.00005","DOIUrl":"https://doi.org/10.1556/1646.2020.00005","url":null,"abstract":"<p><p>A 48-year-old male patient was admitted to our outpatient clinic with complaints of shortness of breath. He also had a holo-diastolic murmur at the right sternal border and an apical impulse being displaced laterally and inferiorly. Transthoracic echocardiography showed a severe aortic regurgitation without aortic valve stenosis and a mildly dilated left ventricle accompanied by an ejection fraction of 55%. The aortic regurgitation jet was eccentric and there were significant holodiastolic flow reversals in the descending thoracic aorta. Surgical management was advised for this patient because of symptomatic severe aortic regurgitation. Then, the patient underwent preoperative coronary angiography through the right femoral artery route. The left coronary ostium could be engaged with a 6 Fr Judkins left diagnostic catheter; however, the catheter jumped through the ascending aorta. Afterwards, the catheter was engaged and again jumped through the ascending aorta. Engagement and jumping cycles observed between successive systole to diastole. In our opinion, this catheter movement is explained by wide pulse pressure, like the severe characteristic physical findings of severe aortic regurgitation. Further studies are needed to understand whether this catheter movement is angiographically evidence of severe aortic regurgitation.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/8d/imas-11-221.PMC9467382.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40450693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN). 波生坦辅助西地那非和单用西地那非治疗新生儿持续性肺动脉高压(PPHN)的疗效、安全性和耐受性
Q2 Medicine Pub Date : 2021-07-16 eCollection Date: 2021-08-01 DOI: 10.1556/1646.2020.00004
J R Vijay Kumar, H S Natraj Setty, M Jayaranganath, C N Manjunath

Background: Pulmonary Arterial Hypertension (PAH) carries a poor prognosis in both adult and pediatric patients. It is a life-threatening condition in newborns. Current recommendations advocate the use of targeted monotherapy as a first-line approach for the treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN). In case of an inadequate clinical response to treatment, an addition of a second or third agent is considered. PAH is usually managed with a phosphodiesterase 5 inhibitor or an endothelin receptor blocker. There are limited pediatric studies that address questions like which class of therapy should be initiated first or if a combination should be initiated together. With this background, the present study was initiated to compare the efficacy, safety, and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in PPHN.

Results: A total of 40 patients were enrolled in the study. Out of them, 26 were males (65%) and 14 were females (35%). PPHN was most commonly seen in the 29 (72.5%) of participants with a history of first order birth. Mean duration of symptoms was 14.05 ± 2.06 days. The participants were randomized to two groups. Group A consisted of total 25 participants that received both bosentan and sildenafil and group B had 15 participants that received sildenafil alone. Both groups were comparable in terms of birth weight and present weight, consanguinity, and mode of delivery. Efficacy was determined by the reduction in mean baseline Pulmonary Artery Systolic Pressure (PASP). PASP in group A was 75.56 ± 10.62 mm Hg and in group B was 64.86 ± 12.25 mm Hg which was not statistically significant (P > 0.05). PASP on the third and seventh day in group A were 43.72 ± 8.63 and 24.47 ± 3.52 mm Hg compared to 42.28 ± 9.43 and 27.276 ± 8.38 respectively in group B which was statistically significant (P < 0.05).There were two deaths each in both groups. Two participants in Group A developed liver function abnormalities. None of the participants in Group B had adverse effects.

Conclusion: Most common clinical manifestations were nonspecific. Cardiovocal syndrome was common in PPHN. We conclude that oral sildenafil treatment is a safe, simple and effective treatment for persistent pulmonary hypertension in newborn. Combination of bosentan with sildenafil is more effective and safe in reducing pulmonary artery (PA) pressures in high-risk patients with PPHN.

背景:肺动脉高压(PAH)在成人和儿童患者中预后都很差。对新生儿来说,这是一种危及生命的疾病。目前的建议提倡使用靶向单药治疗作为治疗新生儿持续性肺动脉高压(PPHN)的一线方法。如果对治疗的临床反应不充分,则考虑添加第二或第三种药物。PAH通常用磷酸二酯酶5抑制剂或内皮素受体阻滞剂治疗。有有限的儿科研究解决的问题,如哪一类的治疗应该首先开始,或者是否应该联合开始。在此背景下,本研究开始比较波生坦作为西地那非和单独西地那非辅助治疗PPHN的疗效、安全性和耐受性。结果:共有40例患者入组研究。其中男性26人(65%),女性14人(35%)。PPHN最常见于29例(72.5%)有第一胎分娩史的参与者。平均症状持续时间为14.05±2.06 d。参与者被随机分为两组。A组共有25名参与者同时接受波生坦和西地那非,B组有15名参与者单独接受西地那非。两组在出生体重和现在体重、血缘关系和分娩方式方面具有可比性。通过降低平均基线肺动脉收缩压(PASP)来确定疗效。A组PASP为75.56±10.62 mm Hg, B组PASP为64.86±12.25 mm Hg,差异无统计学意义(P > 0.05)。A组第3、7天PASP分别为43.72±8.63、24.47±3.52 mm Hg, B组分别为42.28±9.43、27.276±8.38,差异有统计学意义(P < 0.05)。两组各有2例死亡。A组2例出现肝功能异常。B组没有出现不良反应。结论:最常见的临床表现是非特异性的。心声综合征常见于PPHN。结论:口服西地那非治疗新生儿持续性肺动脉高压安全、简便、有效。波生坦联合西地那非降低PPHN高危患者肺动脉压更有效、更安全。
{"title":"Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN).","authors":"J R Vijay Kumar,&nbsp;H S Natraj Setty,&nbsp;M Jayaranganath,&nbsp;C N Manjunath","doi":"10.1556/1646.2020.00004","DOIUrl":"https://doi.org/10.1556/1646.2020.00004","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary Arterial Hypertension (PAH) carries a poor prognosis in both adult and pediatric patients. It is a life-threatening condition in newborns. Current recommendations advocate the use of targeted monotherapy as a first-line approach for the treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN). In case of an inadequate clinical response to treatment, an addition of a second or third agent is considered. PAH is usually managed with a phosphodiesterase 5 inhibitor or an endothelin receptor blocker. There are limited pediatric studies that address questions like which class of therapy should be initiated first or if a combination should be initiated together. With this background, the present study was initiated to compare the efficacy, safety, and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in PPHN.</p><p><strong>Results: </strong>A total of 40 patients were enrolled in the study. Out of them, 26 were males (65%) and 14 were females (35%). PPHN was most commonly seen in the 29 (72.5%) of participants with a history of first order birth. Mean duration of symptoms was 14.05 ± 2.06 days. The participants were randomized to two groups. Group A consisted of total 25 participants that received both bosentan and sildenafil and group B had 15 participants that received sildenafil alone. Both groups were comparable in terms of birth weight and present weight, consanguinity, and mode of delivery. Efficacy was determined by the reduction in mean baseline Pulmonary Artery Systolic Pressure (PASP). PASP in group A was 75.56 ± 10.62 mm Hg and in group B was 64.86 ± 12.25 mm Hg which was not statistically significant (<i>P</i> > 0.05). PASP on the third and seventh day in group A were 43.72 ± 8.63 and 24.47 ± 3.52 mm Hg compared to 42.28 ± 9.43 and 27.276 ± 8.38 respectively in group B which was statistically significant (<i>P</i> < 0.05).There were two deaths each in both groups. Two participants in Group A developed liver function abnormalities. None of the participants in Group B had adverse effects.</p><p><strong>Conclusion: </strong>Most common clinical manifestations were nonspecific. Cardiovocal syndrome was common in PPHN. We conclude that oral sildenafil treatment is a safe, simple and effective treatment for persistent pulmonary hypertension in newborn. Combination of bosentan with sildenafil is more effective and safe in reducing pulmonary artery (PA) pressures in high-risk patients with PPHN.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0d/45/imas-11-216.PMC9467385.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Peculiarities of vascular endothelial growth factor of oral cavity in atopic condition VEGF of oral cavity in atopic condition. 特应性口腔血管内皮生长因子的特点。
Q2 Medicine Pub Date : 2021-07-06 eCollection Date: 2021-08-01 DOI: 10.1556/1646.2020.00002
Nazaryan Rozana, Kryvenko Liudmyla, Gargin Vitaliy

Background and aims: Vascular endothelial growth factor (VEGF) is regarded as a potent stimulating factor for angiogenesis and vascular permeability and probably is connected with an inflammatory reaction. Our study aimed to determine the effect of VEGF in the inflammatory process in the oral mucosa of experimental animals in the modulation of atopic disease.

Materials and methods: Atopic condition was simulated by the ovalbumin model. Obtained specimens of oral mucosa were examined histologically; immunohistochemistry was performed with detection VEGF, CD23, CD20.

Results: Most pronounced changes with twice increased expression activity of VEGF has been detected in the affected areas of the lamina propria and were associated with perivascular inflammatory microinfiltration, but unexpected expression in the epithelial layer has been revealed surround of intraepithelial inflammatory cells mainly. Pronounced correlations have been detected as VEGF and CD23 (r = 0.91), VEGF and CD20 (r = 0.87), CD23 and CD20 (r = 0.89).

Discussion: described the changes in the tissues of the oral mucosa could be served as a basis for the development of preventive measures in patients with atopic diseases.discussion.

Conclusions: Activation of VEGF is connected with accumulation of inflammatory infiltrate represented by B-lymphocytes, activated macrophages, eosinophils with a correlation in atopic process.

背景与目的:血管内皮生长因子(Vascular endothelial growth factor, VEGF)被认为是促进血管生成和血管通透性的有效因子,并可能与炎症反应有关。我们的研究旨在确定VEGF在实验动物口腔黏膜炎症过程中对特应性疾病的调节作用。材料与方法:采用卵清蛋白模型模拟异位。获得的口腔黏膜标本进行组织学检查;免疫组化检测VEGF、CD23、CD20。结果:血管内皮生长因子的变化最明显,表达活性增加了一倍,主要发生在固有层受累区域,并与血管周围炎症微浸润有关,但意外的表达主要发生在上皮内炎症细胞周围。VEGF与CD23 (r = 0.91)、VEGF与CD20 (r = 0.87)、CD23与CD20 (r = 0.89)均存在显著相关性。结论:VEGF的活化与以b淋巴细胞、活化巨噬细胞、嗜酸性粒细胞为代表的炎症浸润的积累有关,在特应性过程中具有相关性。
{"title":"Peculiarities of vascular endothelial growth factor of oral cavity in atopic condition VEGF of oral cavity in atopic condition.","authors":"Nazaryan Rozana,&nbsp;Kryvenko Liudmyla,&nbsp;Gargin Vitaliy","doi":"10.1556/1646.2020.00002","DOIUrl":"https://doi.org/10.1556/1646.2020.00002","url":null,"abstract":"<p><strong>Background and aims: </strong>Vascular endothelial growth factor (VEGF) is regarded as a potent stimulating factor for angiogenesis and vascular permeability and probably is connected with an inflammatory reaction. Our study aimed to determine the effect of VEGF in the inflammatory process in the oral mucosa of experimental animals in the modulation of atopic disease.</p><p><strong>Materials and methods: </strong>Atopic condition was simulated by the ovalbumin model. Obtained specimens of oral mucosa were examined histologically; immunohistochemistry was performed with detection VEGF, CD23, CD20.</p><p><strong>Results: </strong>Most pronounced changes with twice increased expression activity of VEGF has been detected in the affected areas of the lamina propria and were associated with perivascular inflammatory microinfiltration, but unexpected expression in the epithelial layer has been revealed surround of intraepithelial inflammatory cells mainly. Pronounced correlations have been detected as VEGF and CD23 (<i>r</i> = 0.91), VEGF and CD20 (<i>r</i> = 0.87), CD23 and CD20 (<i>r</i> = 0.89).</p><p><strong>Discussion: </strong>described the changes in the tissues of the oral mucosa could be served as a basis for the development of preventive measures in patients with atopic diseases.discussion.</p><p><strong>Conclusions: </strong>Activation of VEGF is connected with accumulation of inflammatory infiltrate represented by B-lymphocytes, activated macrophages, eosinophils with a correlation in atopic process.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4e/ca/imas-11-207.PMC9467381.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40450697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of relationship between the use of cell phone and social networks and sleep quality in students of medical sciences: A cross-sectional study. 评估医学专业学生使用手机和社交网络与睡眠质量之间的关系:一项横断面研究。
Q2 Medicine Pub Date : 2020-09-16 eCollection Date: 2020-09-01 DOI: 10.1556/1646.10.2018.30
Javad Amini Saman, Ali Valinejadi, Saeed Mohammadi, Hassanali Karimpor, Maryam Mirzaei, Rasool Kawyannejad

Introduction: Sleep quality is an essential aspect in human health and function. Considering high prevalence of using smartphones and social networks among students and their impact on sleep quality, this study was conducted to determine the relationship between the overuse of cell phone and addiction to social networks and students' sleep quality.

Materials and methods: This cross-sectional study was conducted in Kermanshah University of Medical Sciences, Kermanshah, Iran in 2018. Using cluster sampling, 321 students from different disciplines were selected. Data gathering tools consisted of the questionnaire of Pittsburgh Sleep Quality Index (PSQI). Cell phone use and addiction to social networks were assessed using Cell Phone Overuse Scale and a researcher-made questionnaire, respectively. Data were analyzed using SPSS software (version 19) and Pearson's correlation test.

Results: The mean total score of sleep quality in students was 6.58 ± 1.05. There was a positive and significant correlation between sleep quality and social networks addiction score (p < 0.05, r = 0.5) and cell phone overuse (p < 0.05, r = 0.44); this is an inverse correlation, because higher scores of the total PSQI denote a lower sleep quality and, in Cell Phone Overuse Scale, higher scores shows overuse.

Conclusions: According to the findings of this study, there was a significant statistical relationship between the overuse of cell phone and social networks and students' sleep quality. In other words, students who have had overuse of cell phones had poorer sleep quality. Therefore, providing effective educational programs to improve the sleep quality in this group is essential.

睡眠质量是影响人体健康和功能的一个重要方面。考虑到学生中智能手机和社交网络的高使用率及其对睡眠质量的影响,本研究旨在确定手机过度使用和社交网络成瘾与学生睡眠质量之间的关系。材料和方法:本横断面研究于2018年在伊朗Kermanshah医科大学进行。采用整群抽样的方法,选取不同学科的321名学生。数据收集工具为匹兹堡睡眠质量指数(PSQI)问卷。手机使用和社交网络成瘾分别通过手机过度使用量表和研究人员制作的问卷进行评估。数据分析采用SPSS (version 19)软件,Pearson相关检验。结果:学生睡眠质量总分平均为6.58±1.05分。睡眠质量与社交网络成瘾评分(p r = 0.5)、手机过度使用(p r = 0.44)呈正相关且显著;这是一个负相关,因为总PSQI得分越高表示睡眠质量越低,在手机过度使用量表中,得分越高表示过度使用。结论:根据本研究的发现,过度使用手机和社交网络与学生睡眠质量之间存在显著的统计关系。换句话说,过度使用手机的学生睡眠质量较差。因此,提供有效的教育项目来改善这一群体的睡眠质量是至关重要的。
{"title":"Assessment of relationship between the use of cell phone and social networks and sleep quality in students of medical sciences: A cross-sectional study.","authors":"Javad Amini Saman,&nbsp;Ali Valinejadi,&nbsp;Saeed Mohammadi,&nbsp;Hassanali Karimpor,&nbsp;Maryam Mirzaei,&nbsp;Rasool Kawyannejad","doi":"10.1556/1646.10.2018.30","DOIUrl":"https://doi.org/10.1556/1646.10.2018.30","url":null,"abstract":"<p><strong>Introduction: </strong>Sleep quality is an essential aspect in human health and function. Considering high prevalence of using smartphones and social networks among students and their impact on sleep quality, this study was conducted to determine the relationship between the overuse of cell phone and addiction to social networks and students' sleep quality.</p><p><strong>Materials and methods: </strong>This cross-sectional study was conducted in Kermanshah University of Medical Sciences, Kermanshah, Iran in 2018. Using cluster sampling, 321 students from different disciplines were selected. Data gathering tools consisted of the questionnaire of Pittsburgh Sleep Quality Index (PSQI). Cell phone use and addiction to social networks were assessed using Cell Phone Overuse Scale and a researcher-made questionnaire, respectively. Data were analyzed using SPSS software (version 19) and Pearson's correlation test.</p><p><strong>Results: </strong>The mean total score of sleep quality in students was 6.58 ± 1.05. There was a positive and significant correlation between sleep quality and social networks addiction score (<i>p</i> < 0.05, <i>r</i> = 0.5) and cell phone overuse (<i>p</i> < 0.05, <i>r</i> = 0.44); this is an inverse correlation, because higher scores of the total PSQI denote a lower sleep quality and, in Cell Phone Overuse Scale, higher scores shows overuse.</p><p><strong>Conclusions: </strong>According to the findings of this study, there was a significant statistical relationship between the overuse of cell phone and social networks and students' sleep quality. In other words, students who have had overuse of cell phones had poorer sleep quality. Therefore, providing effective educational programs to improve the sleep quality in this group is essential.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.10.2018.30","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40450696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assessing the effect of arrival time of physician and cardiopulmonary resuscitation (CPR) team on the outcome of CPR. 评估医师及心肺复苏术团队到达时间对心肺复苏术结果的影响。
Q2 Medicine Pub Date : 2020-09-16 eCollection Date: 2020-09-01 DOI: 10.1556/1646.10.2018.33
Ebrahim Ezzati, Saeed Mohammadi, Hassanali Karimpour, Javad Amini Saman, Afshin Goodarzi, Amir Jalali, Afshin Almasi, Kamran Vafaei, Rasool Kawyannejad

Introduction: Negligence of proper time and poor performance of resuscitation team can lead to more mortality and negative consequences of cardiac arrest, as well as less survival. This study was conducted with objective of determining the arrival time of physician and resuscitation team to survive the victims of cardiopulmonary arrest.

Materials and methods: In this prospective and descriptive-analytic study, the resuscitation performance and the arrival time of resuscitation team in 143 inpatients who had been diagnosed with witnessed cardiopulmonary arrest were examined using a researcher-made checklist. Data analysis was performed using parametric and non-parametric statistical tests and SPSS.

Results: Initial survival rate was 26.6%. In general, the mean time of physician's presence after the code announcement in minutes and seconds was 02:31 ± 01:22. It was also 02:24 ± 01:15 in successful cases and 02:34 ± 01:25 in unsuccessful cases. Independent t-test did not show a significant difference between the physician's presence time and the rate of initial successful resuscitation (p = 0.504). The time of first shock after observing ventricular fibrillation/tachycardia (in minutes and seconds) was 01:30 ± 00:47. According to independent t-test, the aforementioned time was less than the mean time (02:31 ± 01:22) of physician's presence (p < 0.001).

Conclusions: In this study, the initial survival rate in comparison to other regions in the country was almost more favorable and it was similar to global norms. In this study, the starting time of resuscitation was within the acceptable range. There was no relationship between the presence of physician and the initial survival rate of patients, as well as the use of defibrillator (by physician compared to other team members) and intubation with the initial survival rate. This could indicate the adequate performance of resuscitation team in the absence of physician on the condition of having sufficient knowledge and skill.

导读:忽视适当的时机和复苏团队的不良表现会导致更高的死亡率和心脏骤停的负面后果,以及更低的生存率。本研究的目的是确定医生和复苏小组的到达时间,以使心肺骤停患者存活。材料和方法:在本前瞻性和描述性分析研究中,使用研究者自制的检查表对143例被诊断为目击心肺骤停的住院患者的复苏表现和复苏团队的到达时间进行了检查。数据分析采用参数和非参数统计检验及SPSS软件。结果:初始生存率为26.6%。一般情况下,编码公告后医师到场的平均时间(分、秒)为02:31±01:22。成功病例为02:24±01:15,不成功病例为02:34±01:25。独立t检验未显示医生在场时间与初始复苏成功率之间存在显著差异(p = 0.504)。观察室性颤动/心动过速后首次休克时间(分、秒)为01:30±00:47。经独立t检验,上述时间小于医师在场的平均时间(02:31±01:22)(p)。结论:本研究中,与国内其他地区相比,初始生存率几乎更有利,与全球标准相似。本研究中,复苏开始时间在可接受范围内。医生在场与患者的初始存活率之间没有关系,以及除颤器的使用(医生与其他团队成员相比)和插管与初始存活率之间没有关系。这可以表明在医生缺席的情况下,在具备足够的知识和技能的情况下,复苏团队的表现良好。
{"title":"Assessing the effect of arrival time of physician and cardiopulmonary resuscitation (CPR) team on the outcome of CPR.","authors":"Ebrahim Ezzati,&nbsp;Saeed Mohammadi,&nbsp;Hassanali Karimpour,&nbsp;Javad Amini Saman,&nbsp;Afshin Goodarzi,&nbsp;Amir Jalali,&nbsp;Afshin Almasi,&nbsp;Kamran Vafaei,&nbsp;Rasool Kawyannejad","doi":"10.1556/1646.10.2018.33","DOIUrl":"https://doi.org/10.1556/1646.10.2018.33","url":null,"abstract":"<p><strong>Introduction: </strong>Negligence of proper time and poor performance of resuscitation team can lead to more mortality and negative consequences of cardiac arrest, as well as less survival. This study was conducted with objective of determining the arrival time of physician and resuscitation team to survive the victims of cardiopulmonary arrest.</p><p><strong>Materials and methods: </strong>In this prospective and descriptive-analytic study, the resuscitation performance and the arrival time of resuscitation team in 143 inpatients who had been diagnosed with witnessed cardiopulmonary arrest were examined using a researcher-made checklist. Data analysis was performed using parametric and non-parametric statistical tests and SPSS.</p><p><strong>Results: </strong>Initial survival rate was 26.6%. In general, the mean time of physician's presence after the code announcement in minutes and seconds was 02:31 ± 01:22. It was also 02:24 ± 01:15 in successful cases and 02:34 ± 01:25 in unsuccessful cases. Independent <i>t</i>-test did not show a significant difference between the physician's presence time and the rate of initial successful resuscitation (<i>p</i> = 0.504). The time of first shock after observing ventricular fibrillation/tachycardia (in minutes and seconds) was 01:30 ± 00:47. According to independent <i>t</i>-test, the aforementioned time was less than the mean time (02:31 ± 01:22) of physician's presence (<i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>In this study, the initial survival rate in comparison to other regions in the country was almost more favorable and it was similar to global norms. In this study, the starting time of resuscitation was within the acceptable range. There was no relationship between the presence of physician and the initial survival rate of patients, as well as the use of defibrillator (by physician compared to other team members) and intubation with the initial survival rate. This could indicate the adequate performance of resuscitation team in the absence of physician on the condition of having sufficient knowledge and skill.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/88/imas-11-139.PMC9467330.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40450698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial. 肩峰下皮质类固醇注射与皮下5%葡萄糖治疗慢性肩袖肌腱病变:一项短期随机临床试验
Q2 Medicine Pub Date : 2019-11-11 eCollection Date: 2020-09-01 DOI: 10.1556/1646.11.2019.18
Asadollah Amanollahi, Mahsa Asheghan, Seyed Ebrahim Hashemi

Aim: The aim of this study is to compare subcutaneous 5% dextrose versus subacromial corticosteroid injection for the treatment of chronic rotator cuff tendinopathy.

Methods: We carried out a randomized clinical trial with two parallel groups at a university hospital. Overall, 57 (32 women) were included in two groups of corticosteroid (n = 29) and dextrose (n = 28). The mean pain score was 6.6 (1.0). We used a visual analog scale for pain and goniometry for the range of motion. The measurements were repeated 1 month after the interventions. For corticosteroid, a single injection of triamcinolone and 1% lidocaine, and for dextrose, a mixture of 5% dextrose and 2% lidocaine three times weekly were prescribed.

Results: Both interventions were effective in decreasing pain compared to the baseline (both p < 0.001). The difference in pain between the two groups was nearly significant 1-month post-intervention (p = 0.052). The comparison of the two groups in considerable pain reduction (≥2.8) was in favor of dextrose (p = 0.046). The differences in the range of motion were not conclusive. None of the participants reported an important adverse effect.

Conclusion: The 5% dextrose treatment is at least as effective as corticosteroid for reducing pain in patients with rotator cuff tendinopathy.

目的:本研究的目的是比较5%葡萄糖皮下注射与肩峰下皮质类固醇注射治疗慢性肩袖肌腱病变的疗效。方法:在某大学医院进行两组平行随机临床试验。总的来说,57名(32名女性)被分为皮质类固醇(n = 29)和葡萄糖(n = 28)两组。平均疼痛评分6.6分(1.0分)。我们用视觉模拟量表来衡量疼痛,用角度测量法来衡量活动范围。干预后1个月重复测量。对于皮质类固醇,一次注射曲安奈德和1%利多卡因,对于葡萄糖,5%葡萄糖和2%利多卡因的混合物,每周三次。结果:与基线相比,两种干预措施在减轻疼痛方面均有效(p = 0.052)。两组在疼痛明显减轻(≥2.8)方面比较,葡萄糖组优于葡萄糖组(p = 0.046)。运动范围的差异并不是决定性的。没有参与者报告有严重的不良反应。结论:5%葡萄糖治疗在减轻肩袖肌腱病变患者疼痛方面至少与皮质类固醇一样有效。
{"title":"Subacromial corticosteroid injection versus subcutaneous 5% dextrose in patients with chronic rotator cuff tendinopathy: A short-term randomized clinical trial.","authors":"Asadollah Amanollahi,&nbsp;Mahsa Asheghan,&nbsp;Seyed Ebrahim Hashemi","doi":"10.1556/1646.11.2019.18","DOIUrl":"https://doi.org/10.1556/1646.11.2019.18","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study is to compare subcutaneous 5% dextrose versus subacromial corticosteroid injection for the treatment of chronic rotator cuff tendinopathy.</p><p><strong>Methods: </strong>We carried out a randomized clinical trial with two parallel groups at a university hospital. Overall, 57 (32 women) were included in two groups of corticosteroid (<i>n</i> = 29) and dextrose (<i>n</i> = 28). The mean pain score was 6.6 (1.0). We used a visual analog scale for pain and goniometry for the range of motion. The measurements were repeated 1 month after the interventions. For corticosteroid, a single injection of triamcinolone and 1% lidocaine, and for dextrose, a mixture of 5% dextrose and 2% lidocaine three times weekly were prescribed.</p><p><strong>Results: </strong>Both interventions were effective in decreasing pain compared to the baseline (both <i>p</i> < 0.001). The difference in pain between the two groups was nearly significant 1-month post-intervention (<i>p</i> = 0.052). The comparison of the two groups in considerable pain reduction (≥2.8) was in favor of dextrose (<i>p</i> = 0.046). The differences in the range of motion were not conclusive. None of the participants reported an important adverse effect.</p><p><strong>Conclusion: </strong>The 5% dextrose treatment is at least as effective as corticosteroid for reducing pain in patients with rotator cuff tendinopathy.</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1556/1646.11.2019.18","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40450692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction? 促性腺激素释放激素激动剂的使用真的会导致甲状腺功能障碍吗?
Q2 Medicine Pub Date : 2019-11-11 eCollection Date: 2020-09-01 DOI: 10.1556/1646.10.2018.32
Nafiye Yilmaz, Necati Hancerliogullari, Mustafa Kara, Yaprak Engin-Ustun

Objectives: Gonadotropin-releasing hormone agonist (GnRHa) could influence the levels of sex hormones and thyroid hormones. The aim of this study was to investigate the effect of GnRHa on thyroid function.

Materials and methods: The data of the patients were collected from the registrations of July 2014-October 2014. A total of 41 women who underwent one-time IVF cyclus were evaluated in this cross-sectional study. The patients were categorized into two groups according to the serum T3, T4, and TSH levels before and 2 weeks' after the administration of GnRHa.

Results: Mean basal TSH and mean TSH levels on hCG day were 1.98 ± 0.77 and 1.75 ± 0.70, respectively. The difference between the two groups was statistically significant (p < 0.05). GnRHa did not lead to statistically significant difference on serum-free T3 and T4 levels.

Conclusions: In conclusion, our results demonstrate that GnRHa led to a decrease on serum TSH level. Serum-free T3 and T4 levels were remained unchanged and this might be due to early measurement of the hormone levels (just 2 weeks later from GnRHa administration).

目的:促性腺激素释放激素激动剂(GnRHa)对性激素和甲状腺激素水平的影响。本研究旨在探讨GnRHa对甲状腺功能的影响。材料与方法:患者资料收集于2014年7月- 2014年10月登记。在这项横断面研究中,共有41名接受过一次性试管婴儿周期的妇女进行了评估。根据给药前和给药后2周血清T3、T4、TSH水平将患者分为两组。结果:hCG日平均基础TSH和平均TSH水平分别为1.98±0.77和1.75±0.70。两组患者t3、T4水平差异有统计学意义。结论:总之,我们的研究结果表明,GnRHa导致血清TSH水平降低。血清游离T3和T4水平保持不变,这可能是由于早期测量激素水平(仅在GnRHa给药后2周)。
{"title":"Is gonadotropin-releasing hormone agonist usage really leading to thyroid dysfunction?","authors":"Nafiye Yilmaz,&nbsp;Necati Hancerliogullari,&nbsp;Mustafa Kara,&nbsp;Yaprak Engin-Ustun","doi":"10.1556/1646.10.2018.32","DOIUrl":"https://doi.org/10.1556/1646.10.2018.32","url":null,"abstract":"<p><strong>Objectives: </strong>Gonadotropin-releasing hormone agonist (GnRHa) could influence the levels of sex hormones and thyroid hormones. The aim of this study was to investigate the effect of GnRHa on thyroid function.</p><p><strong>Materials and methods: </strong>The data of the patients were collected from the registrations of July 2014-October 2014. A total of 41 women who underwent one-time IVF cyclus were evaluated in this cross-sectional study. The patients were categorized into two groups according to the serum T<sub>3</sub>, T<sub>4</sub>, and TSH levels before and 2 weeks' after the administration of GnRHa.</p><p><strong>Results: </strong>Mean basal TSH and mean TSH levels on hCG day were 1.98 ± 0.77 and 1.75 ± 0.70, respectively. The difference between the two groups was statistically significant (<i>p</i> < 0.05). GnRHa did not lead to statistically significant difference on serum-free T<sub>3</sub> and T<sub>4</sub> levels.</p><p><strong>Conclusions: </strong>In conclusion, our results demonstrate that GnRHa led to a decrease on serum TSH level. Serum-free T<sub>3</sub> and T<sub>4</sub> levels were remained unchanged and this might be due to early measurement of the hormone levels (just 2 weeks later from GnRHa administration).</p>","PeriodicalId":45181,"journal":{"name":"Interventional Medicine and Applied Science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d9/68/imas-11-136.PMC9467336.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Interventional Medicine and Applied Science
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1